Swedish Orphan Biovitrum AB (SWOBY)
23.28
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Swedish Orphan Biovitrum Total Liabilities (Quarterly) : 4.291B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.291B |
| December 31, 2025 | 3.223B |
| September 30, 2025 | 3.294B |
| June 30, 2025 | 3.114B |
| March 31, 2025 | 3.094B |
| December 31, 2024 | 3.181B |
| September 30, 2024 | 3.461B |
| June 30, 2024 | 3.477B |
| March 31, 2024 | 3.611B |
| December 31, 2023 | 3.985B |
| September 30, 2023 | 3.787B |
| June 30, 2023 | 4.389B |
| March 31, 2023 | 2.515B |
| December 31, 2022 | 2.493B |
| September 30, 2022 | 2.331B |
| June 30, 2022 | 2.352B |
| March 31, 2022 | 2.688B |
| December 31, 2021 | 2.812B |
| September 30, 2021 | 2.856B |
| June 30, 2021 | 2.926B |
| March 31, 2021 | 3.135B |
| December 31, 2020 | 3.447B |
| September 30, 2020 | 2.832B |
| June 30, 2020 | 2.578B |
| March 31, 2020 | 2.803B |
| Date | Value |
|---|---|
| December 31, 2019 | 3.069B |
| September 30, 2019 | 1.740B |
| June 30, 2019 | 1.638B |
| March 31, 2019 | 1.670B |
| December 31, 2018 | 918.47M |
| September 30, 2018 | 873.36M |
| June 30, 2018 | 477.76M |
| March 31, 2018 | 498.04M |
| December 31, 2017 | 513.22M |
| September 30, 2017 | 578.61M |
| June 30, 2017 | 559.37M |
| March 31, 2017 | 528.99M |
| December 31, 2016 | 517.12M |
| September 30, 2016 | 516.02M |
| June 30, 2016 | 511.42M |
| March 31, 2016 | 434.44M |
| December 31, 2015 | 455.33M |
| September 30, 2015 | 242.28M |
| June 30, 2015 | 226.21M |
| March 31, 2015 | 227.39M |
| December 31, 2014 | 266.40M |
| September 30, 2014 | 254.95M |
| June 30, 2014 | 264.85M |
| March 31, 2014 | 274.65M |
| December 31, 2013 | 272.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Hansa Biopharma AB | 150.89M |
| BioArctic AB | 50.51M |
| Diamyd Medical AB | 9.292M |
| BONESUPPORT HOLDING AB | 18.89M |
| BioInvent International AB | 10.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.530B |
| Shareholders Equity (Quarterly) | 4.238B |
| Debt to Equity Ratio | 0.4721 |
| Current Ratio | 0.7048 |
| Net Debt Paydown Yield | -0.72% |